2011
DOI: 10.1016/j.ijbiomac.2011.03.016
|View full text |Cite
|
Sign up to set email alerts
|

Exploring glycolate oxidase (GOX) as an antiurolithic drug target: Molecular modeling and in vitro inhibitor study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 35 publications
(33 reference statements)
1
15
0
Order By: Relevance
“…In this pathway, glycolate can be converted to glyoxylate by oxidation and then glyoxylate is finally converted to oxalate. 32 The relatively low levels of glycolate and oxalate, together with the high level of glyoxylate, were observed in the RA group in our study. However, the reason for this perturbation is not yet known and further studies need to be carried out in the future.…”
Section: Discussionsupporting
confidence: 43%
“…In this pathway, glycolate can be converted to glyoxylate by oxidation and then glyoxylate is finally converted to oxalate. 32 The relatively low levels of glycolate and oxalate, together with the high level of glyoxylate, were observed in the RA group in our study. However, the reason for this perturbation is not yet known and further studies need to be carried out in the future.…”
Section: Discussionsupporting
confidence: 43%
“…In ex vivo conditions, better results were observed than in vitro. This phenomenon may be described as inhibition of calcium oxalate crystals which is due to inhibition of glycolate oxidase (GOX) by quercetin [19]. In our analysis, a significant amount of quercetin was found in mother extract and DCM fraction.…”
Section: Resultsmentioning
confidence: 57%
“…Quercetin and kaempherol, the active components of TT, were found to be non-competitive and competitive inhibitors of GOX, respectively. [30]…”
Section: Pharmacological Activitiesmentioning
confidence: 99%